Literature DB >> 33486703

Differential imaging of atypical demyelinating lesions of the central nervous system.

Matteo Paoletti1, Shaun Ivan Muzic2, Francesca Marchetti2, Lisa Maria Farina3, Stefano Bastianello3,4, Anna Pichiecchio3,4.   

Abstract

The detection of atypical and sometimes aggressive or tumefactive demyelinating lesions of the central nervous system often poses difficulties in the differential diagnosis. The clinical presentation is generally aspecific, related to the location and similar to a number of different lesions, including neoplasms and other intracranial lesions with mass effect. CSF analysis may also be inconclusive, especially for lesions presenting as a single mass at onset. As a consequence, a brain biopsy is frequently performed for characterization. Advanced MRI imaging plays an important role in directing the diagnosis, reducing the rate of unnecessary biopsies and allowing a prompt start of therapy that is often crucial, especially in the case of infratentorial lesions. In this review, the main pattern of presentation of atypical inflammatory demyelinating diseases is discussed, with particular attention on the differential diagnosis and how to adequately define the correct etiology.

Entities:  

Keywords:  AIIDL; Atypical demyelinating lesions; Multiple sclerosis; TDL; Tumefactive demyelinating lesion

Mesh:

Year:  2021        PMID: 33486703     DOI: 10.1007/s11547-021-01334-y

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  62 in total

Review 1.  MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

Authors:  A Seewann; C Enzinger; M Filippi; F Barkhof; A Rovira; A Gass; D Miller; X Montalban; A Thompson; T Yousry; M Tintore; N de Stefano; J Palace; M Rovaris; C Polman; F Fazekas
Journal:  J Neurol       Date:  2007-11-15       Impact factor: 4.849

Review 2.  Atypical inflammatory demyelinating syndromes of the CNS.

Authors:  Todd A Hardy; Stephen W Reddel; Michael H Barnett; Jacqueline Palace; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2016-08       Impact factor: 44.182

3.  Cerebral tumefactive demyelinating lesions.

Authors:  Wei Qi; G E Jia; Xinsheng Wang; Maozhi Zhang; Zhenyu Ma
Journal:  Oncol Lett       Date:  2015-07-10       Impact factor: 2.967

4.  Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.

Authors:  Mirja Wallner-Blazek; Alex Rovira; Massimo Fillipp; Mara A Rocca; David H Miller; Klaus Schmierer; Jette Frederiksen; Achim Gass; Hugo Gama; Charles P Tilbery; Antonio J Rocha; José Flores; Frederik Barkhof; Alexandra Seewann; Jacqueline Palace; Tarek Yousry; Xavier Montalban; Christian Enzinger; Franz Fazekas
Journal:  J Neurol       Date:  2013-04-26       Impact factor: 4.849

Review 5.  Pseudotumoral forms of multiple sclerosis: report of 14 cases and review of the literature.

Authors:  Lara Mauri-Fábrega; María Díaz-Sánchez; José Luis Casado-Chocán; Antonio José Uclés-Sánchez
Journal:  Eur Neurol       Date:  2014-06-04       Impact factor: 1.710

6.  MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.

Authors:  C H Suh; H S Kim; S C Jung; C G Choi; S J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2018-08-16       Impact factor: 3.825

7.  Conventional and advanced magnetic resonance imaging in tumefactive demyelination.

Authors:  Jitender Saini; Somenath Chatterjee; Bejoy Thomas; Chandrasekharan Kesavadas
Journal:  Acta Radiol       Date:  2011-10-24       Impact factor: 1.990

8.  Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.

Authors:  Masaki Kobayashi; Yuko Shimizu; Noriyuki Shibata; Shinichiro Uchiyama
Journal:  J Neurol       Date:  2014-07-18       Impact factor: 4.849

Review 9.  Baló's concentric sclerosis.

Authors:  Todd A Hardy; David H Miller
Journal:  Lancet Neurol       Date:  2014-07       Impact factor: 44.182

10.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

View more
  3 in total

Review 1.  Diffusion weighted imaging and diffusion kurtosis imaging in abdominal oncological setting: why and when.

Authors:  Vincenza Granata; Roberta Fusco; Andrea Belli; Ginevra Danti; Eleonora Bicci; Carmen Cutolo; Antonella Petrillo; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2022-06-09       Impact factor: 3.698

2.  Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.

Authors:  Vincenza Granata; Roberta Fusco; Andrea Belli; Valentina Borzillo; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Alessandro Ottaiano; Guglielmo Nasti; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2022-03-28       Impact factor: 2.965

Review 3.  A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.

Authors:  Federica De Muzio; Francesca Grassi; Federica Dell'Aversana; Roberta Fusco; Ginevra Danti; Federica Flammia; Giuditta Chiti; Tommaso Valeri; Andrea Agostini; Pierpaolo Palumbo; Federico Bruno; Carmen Cutolo; Roberta Grassi; Igino Simonetti; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.